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Abstract 
The aim of this study was to assess the use of ambulatory acoustic cardiography during the initial data 
collection of the longitudinal study of a rural population in Switzerland (n=297, mean age 48.9 ±16.5 years, 
57% female). Ambulatory acoustic cardiography non-invasively can assess sleep disordered breathing (SDB) 
and provides markers of left ventricular systolic and diastolic dysfunction. The percentage of the third heart 
sound detected during sleep decreased significantly across age groups (age < 40 years, 40-60 years, > 60 
years) for both genders (males, p=0.04; females, p=0.02). The percentage of a fourth heart sound detected 
exhibited an increasing trend for both genders with age suggesting increased diastolic dysfunction with aging. 
Mean electromechanical activation time (EMAT) during sleep was within the normal range across age groups 
and both genders (male 93.7 ± 11.6 ms, female 94.6 ± 13.0 ms), and did not vary significantly with age. A 
large proportion of subjects had a high likelihood of sleep disordered breathing (17.6%). Baseline              
characteristics categorized by SDB severity indicate increasing age, male gender and being overweight                   
(BMI ≥ 25) to be associated with greater SDB severity. Acoustic cardiography findings categorized by SDB 
severity reveal increased nocturnal non-dipping heart rate, presence of atrial fibrillation, prolonged QRS 
duration and QTc interval, increased percentage of fourth heart sound detected, and longer EMAT to be 
significantly associated with greater SDB severity. Overall, acoustic cardiography detected a very low 
prevalence of systolic dysfunction, age-related increases in diastolic dysfunction and a moderate prevalence of 
sleep disordered breathing. 
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Introduction 
 The life expectancy in Switzerland is particularly 
high and due, in part, to nationwide patient 
management strategies aimed at lowering blood 
pressure [1] and controlling hyperlipidemia to decrease 
the number of deaths due to acute coronary disease [2] 
and stroke, but cardiovascular disease remains the 
leading cause of mortality and morbidity. The 
longitudinal SWICOS cohort study [3] is intended to 
examine and longitudinally follow health status and 
disease risk factors in select rural Swiss populations to 
support development of new implementable and 
successful preventive strategies for healthy ageing. In 
addition to conventional epidemiological parameters of 
cardiovascular health, SWICOS uses contemporary 
technologies including ambulatory acoustic cardiography 
monitoring [4] as part of the establishment of a                 
well-defined database of health status. 
 Acoustic cardiography evaluation involves a              
24-hour ambulatory Holter-type recording performed 
using a device that stores continuous ECG, heart sound 
and respiratory data (AUDICOR, Inovise Medical, Inc., 
Beaverton, Oregon, USA). Analysis of the acoustic 
cardiography recording results in parameters to evaluate 
diastolic function, in particular, the presence of a fourth 
heart sound (S4), which has been shown to be 
associated with increased left ventricular stiffness [5]. 
Acoustic cardiography also produces parameters to 
assess systolic function including the presence of a third 
heart sound (S3) shown to be correlated with elevated 
filling pressure [6], electromechanical activation time 
(EMAT) that reflects the time required for the left 
ventricle to generate enough pressure to close the 
mitral valve [7] and the Systolic Dysfunction Index (SDI, 
a composite score of ECG and heart sound parameters). 
 In addition, ambulatory monitoring with acoustic 
cardiography produces an automated measure of the 
severity of sleep-disordered breathing [8]. 
 Results from ambulatory acoustic cardiography 
have previously been reported on small asymptomatic 
[9] and heart failure populations [10]. Lausanne, 
Switzerland has been the setting for a population-based 
survey of cardiovascular risk factors (CoLaus) [11] and, 
separately, at-home sleep disordered breathing 
assessment (HypnoLaus) [12]. However, little data 
exists on the associations between sleep disordered 
breathing and left ventricular systolic / diastolic function 
within a rural Swiss population. 
 The aim of this study was to assess the 
applicability of the use of acoustic cardiography in 
voluntary participants of the recently begun longitudinal 
study of a rural population in Switzerland. In this paper 
we report only the acoustic cardiography findings for the 
initial data collection to evaluate systolic and diastolic 
heart function and sleep disorders. 
Materials and Methods 
 Ambulatory acoustic cardiographic Holter data 
were collected between April, 2015 and January, 2017 
from residents within the region of Cama, Switzerland 
age 15 years and older that were willing to participate 
long-term in the SWICOS study. There were no 
exclusion criteria. The study received approval from the 
ethics committee of Nordwest und Zentralschweiz 
(reference number EKNZ 2014-209; NCT02282748). 
 Informed consent was obtained from all 
subjects. Anamnestic data was obtained through 
questionnaire and interview of the subject. Patient 
height and weight were measured during initial 
examination.  
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Acoustic Cardiographic Holter Recordings 
 The ambulatory acoustic cardiography recording 
was obtained by placing standard ECG electrodes in 
modified limb locations and dual-purpose ECG / sound 
AUDICOR sensors placed in either the standard V4 
position or both the V3 and V4 precordial positions while 
the subject was in a supine position (Figure 1). The 
main AUDICOR recording device was secured on the 
upper chest wall using two standard ECG snap-type 
electrodes. Adequate quality of the ECG and heart sound 
signals was confirmed visually by study personnel before 
starting the recording. Simultaneous ECG, heart sound 
and respiration data were recorded simultaneously for 
the duration of the recording and partitioned into awake 
and sleep periods. 
 The ECG signals were overread by trained Holter 
technicians for ectopy and rhythm abnormalities. 
Automated analysis of the ECG data produced results for 
QRS duration, QTc interval and heart rate. 
 The ECG and heart sound data underwent 
automated analysis for the presence of diastolic heart 
sounds (S3 and S4 Strength), electromechanical 
activation time (EMAT), electromechanical activation 
time divided by the cardiac cycle interval (EMATc) and 
the Systolic Dysfunction Index (SDI). The AUDICOR 
automated heart sound algorithm is a hidden Markov 
model with inputs derived from a 6-level stationary 
wavelet transformation of the acoustic signal and from 
select fiducial times of the simultaneous ECG signal. The 
output includes a segmentation of the acoustic signal 
into individual heart sounds, as well as measurements 
derived from that segmentation. The S3 and S4 strength 
parameters are a combination of intensity and 
persistence of the acoustic signal within the segments 
appropriate in timing for those heart sounds. S3 / S4 
Strength is expressed on a 0 to 10 scale where if the 
strength is ≥ 5.0 a third or fourth heart sound is 
considered present. EMAT is the interval from Q onset to 
the mitral component of the first heart sound expressed 
in msec, and is prolonged in systolic heart failure [4].  
EMATc is equal to EMAT divided by the length of the 
cardiac cycle and is expressed as a percentage with 
values ≥15% indicating poor prognosis from left 
ventricular systolic dysfunction [13]. Acoustic 
cardiography produces the systolic dysfunction index 
(SDI) which is non-linear combination of QRS duration, 
QR interval, S3 strength and EMATc and is mapped to a 
continuous scale of 0 to 10. The multiparameter score 
SDI is expressed on a 0 to 10 scale and when ≥ 5.0 
indicates left ventricular systolic dysfunction and when ≥ 
7.5 indicates severe left ventricular systolic dysfunction 
with elevated filling pressure. 
 The acoustic cardiographic analysis for ECG is 
similar to standard Holter and encompasses the entire 
recording while the analysis of heart sounds and          
Figure 1: Acoustic cardiography monitoring device, sensor and 
placement on torso 
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sleep-disordered breathing occurs during sleep hours. 
Results from the analysis during sleep include the 
percentage of third and fourth heart sounds detected 
(% S3 / S4 Strength ≥ 5.0), the average value of EMAT 
(msec), percentage of EMATc ≥ 15 (%), percentage of 
SDI ≥ 5 (%), and percentage of SDI ≥ 7.5 (%).  
 Signals from the AUDICOR triaxial 
accelerometer located on the chest wall are bandpass 
filtered and then undergo further signal processing to 
create a pseudo-respiration signal that is used to detect 
individual sleep-disordered breathing events (i.e., 
apneas and hypopneas). The timing and duration of 
individual SDB events are used to create a sleep 
disordered breathing severity index (events per hour). 
Apnea and hypopnea events greater than ten seconds in 
duration that meet certain physiological timing 
constraints and occur during quiescent periods are 
considered valid SDB events. These are totaled and 
divided by total sleep time to create the SDB severity 
index. The SDB algorithm was developed on learn 
portions of large databases from subjects undergoing 
overnight polysomnography (PSG) .  The PSG data was 
collected, annotated by trained experts for episodes of 
sleep disordered breathing, and scored in accordance 
with American Association of Sleep Medicine (AASM) 
2007 standards including generation of the                    
apnea / hypopnea index (AHI). The AUDICOR sleep 
disordered severity index was developed to correlate 
with the PSG AHI and categorize subjects into groups of 
borderline, low probability and probable likelihood. 
Dillier et al. [8] published performance results for the 
AUDICOR SDB severity index against the AASM 
thresholds that uses AHI to classify mild, moderate and 
severe sleep apnea (mild, 5 ≤ AHI < 15; moderate, 15 
≤ AHI < 30; severe, AHI ≥ 30). In addition, the sound 
data allows the detection of snore events distinguished 
as period, high frequency signals that are used to 
determine the percentage of sleep time with snore 
events. This parameter was validated against PSG snore 
events [8]. 
 The clinical performance of all the parameters 
obtained through acoustic cardiography by the 
AUDICOR device have been tested and validated in 
previous invasive and non-invasive studies with 
independent clinical correlates (e.g., cardiac 
catheterization, pressure / volume loops, 
echocardiography, overnight polysomnography) [5-10].  
Statistical Analysis 
 The results are presented as percentages for 
categorical variables and analyzed using the Pearson             
chi-square test or Fisher’s exact test as appropriate. 
Continuous normally distributed variables are expressed 
as means ± 1 standard deviation (SD) and compared 
using the Student’s two-tailed unpaired t-test. To test 
for differences among groups one-way ANOVA was 
used.  Continuous non-normally distributed variables are 
expressed as medians and interquartile ranges and 
analyzed using the Mann-Whitney U test or                  
Kruskal–Wallis as appropriate.  P values < 0.05 to be 
considered statistically significant. The statistics 
software used for analysis was IBM SPSS Statistics 
(version 23, IBM Corp. Armonk, NY, USA). 
Results 
 A total of 307 subjects from one location in 
Switzerland were enrolled. There were 10 subjects 
excluded from the acoustic cardiography analysis due to 
poor signal quality. Of the 297 subjects with suitable 
acoustic cardiography recordings, 284 included the 
sleep period and had at least 4 hours of sleep necessary 
to assess sleep-disordered breathing. 
 The baseline characteristics of the 297 subjects 
(female 57%) with ambulatory acoustic cardiography 
recordings (male age range 16 to 89 years; female age 
range 15 to 87 years) are presented in Table 1, for all 
ages and within the age categories used in further 
analyses (age < 40, 40 to 60, and > 60 years). As 
expected, age over 40 years was associated with 
significantly higher prevalence of hypertension, 
hyperlipidemia, increased BMI, coronary artery disease, 
myocardial infarction and heart failure.  
 There were no significant differences in mean 
sleep time between males and females, or across age 
ranges (mean sleep time: all 4.9 ± 1.5, males 4.7 ± 1.4, 
females 5.0 ± 1.5 hours). 
 In aggregate, females had a significantly higher 
heart rate during sleep than males (62.2 ± 8.3 vs. 58.8 
± 8.9 bpm, p=0.018) and also significantly higher heart 
rate during wake than males (77.7 ± 8.8 vs. 74.4 ± 
11.5 bpm, p=0.005), Figure 2. Within age groups, only 
the 40-60 year group had a significant difference in 
heart rate across gender (sleep p=0.02; awake 
p=0.007). Nocturnal non-dipping of heart rate was 
defined as sleep / awake heart rate ratio greater than 
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Figure 2: Mean awake and sleep heart rate for males and females 
Figure 3: Nocturnal non-dipping of heart rate for males 
and females 
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0.90 [14]. Among 287 subjects, 30 (10.5%) had 
nocturnal non-dipping of heart rate (Figure 3; males 
13.8%, females 7.9%). The subjects with nocturnal        
non-dipping of heart rate were on average 4 years older 
than those without (52.4 ± 16 vs. 48.5 ± 16 years), with 
more diabetes, hypertension, higher BMI and they were 
less frequently current smokers. However, none of these 
reached statistical significance. 
 The percentage of S3 detected during sleep 
decreased significantly across age groups for both males 
and females (males p=0.04, females p=0.02), and 
differed significantly between males and females only in 
the 40 to 60 year old group (p=0.02), Figure 4. For ages 
> 40 years, the mean values of the percentage of S3 
detected were 4% or less. In contrast, the percentage of 
S4 detected exhibited an increasing trend with age for 
both males and females; however, only females had a 
significant difference across age groups (females 
p=0.04, males p=0.09), Figure 4. 
 Mean electromechanical activation time during 
sleep was less than 100 msec across age groups and 
both genders (male 93.7 ± 11.6 ms, female 94.6 ± 13.0 
ms), and did not vary significantly (Figure 5). The 
percentage of EMATc ≥ 15 during sleep, Figure 5, was 
very low with a median of 0.2% (IQR 0.04, 0.94%). 
Males had a significant difference in %EMATc ≥ 15 
during sleep across age groups while females did not 
(males p=0.01, females p=0.50) although the absolute 
percentage did not suggest LV systolic dysfunction. 
The percentage of SDI ≥ 5.0 and percentage of SDI ≥ 
7.5 during sleep was very low with medians of 0.06% 
(IQR 0, 0.3%) and 0% (IQR 0, 0.07%), respectively 
(Figure 6). 
 While both males and females had increasing                     
sleep-disordered breathing severity trends with age, only 
female SDB trends with aging reached statistical 
significance (males p=0.59, females p=0.05), Figure 7. 
The sleep-disordered breathing severity index is used in 
the acoustic cardiography report to produce statements 
concerning the likelihood of SDB as low probability, 
borderline and probable. Baseline characteristics 
categorized by SDB likelihood statement indicate 
increasing age, male gender and being overweight (BMI 
≥ 25) to be associated with greater SDB severity              
(Table 2). Within the highest severity SDB group, 66% 
of the population were either overweight or obese. ECG 
findings categorized by SDB likelihood statement reveal 
increased nocturnal non-dipping heart rate, presence of 
atrial fibrillation, prolonged QRS duration and QTc 
interval to be increased with greater SDB severity  
(Table 3). Acoustic cardiography findings categorized by 
SDB likelihood show increased percentage of S4, 
prolonged EMAT and EMATc ≥ 15% to be significantly 
associated with greater SDB severity. The percentage of 
time spent snoring is also increased with greater SDB 
severity suggesting the disorder to be obstructive rather 
than central in nature.  
Discussion 
 The results provided in this paper represent the 
acoustic cardiography results from the initial data 
collection (n=297) of the longitudinal SWICOS study 
conducted in the region of Cama, Switzerland. Recent 
studies have shown that both short (typically < 5-6 
hours) and long (typically >8-9 hours) durations of sleep 
are associated with increased mortality, obesity and risk 
of CVD. The mean sleep time (4.9 ± 1.5 hours) for our 
population would be regarded as "short" in duration with 
no significant differences related to gender or aging. 
Cappuccio et al. have shown that short sleep duration is 
associated with greater risk of developing or dying of 
coronary heart disease or stroke [15], and Ford [16] 
reported increased 10-year risk of CVD with short sleep 
duration (14.5%). Our results suggest the need for 
lifestyle modifications and public education to improve 
sleep duration to reduce cardiovascular risk. 
 Although considered physiologic in those under 
40 years, the presence of a diastolic third heart sound 
has been shown to identify patients with more advanced 
heart failure [17] and has been associated with adverse 
outcomes in both heart failure and acute myocardial 
infarction [18, 19]. The S3 occurs in diastole during 
early passive filling and is caused by the sudden 
deceleration of rapid filling into a distended or stiff 
ventricle [20]. Using acoustic cardiography on short 
recordings, detection of a third heart sound has been 
correlated to elevated LV end-diastolic pressure and 
reduced ejection fraction [21], and in emergency 
department patients with signs or symptoms of acute 
decompensated heart failure has been found to be 
specific for primary heart failure [22]. We found a 
decrease in the percentage of S3 detected during sleep 
after age 40 years with a mean of 4% or less detected 
after age 40 years similar to the results of Dillier et al. 
using ambulatory monitoring with acoustic cardiography 
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Figure 4: Diastolic third and fourth heart sounds, percentage detected during sleep 
Figure 5: Mean electromechanical activation time (EMAT) and percentage of EMATc ≥15 during 
sleep 
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Figure 6: Percentage of SDI ≥ 5.0 and SDI ≥ 7.5 during sleep 
Figure 7: Sleep-disordered breathing severity index during 
sleep for males and females 
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in an asymptomatic population [9]. However, in chronic 
and acute heart failure patients using ambulatory 
acoustic cardiography Dillier et al. found much higher 
prevalence of percentage of S3 (chronic HF                     
13.0 ± 20.0%; acute HF 25.0 ± 22.0%) [10]. Thus, our 
findings confirm those of Dillier et al. in an 
asymptomatic population and suggest a high percentage 
of S3 detected at night has good specificity as a marker 
of cardiac disease. 
 The fourth heart sound occurs in the active 
filling phase of diastole during atrial contraction by the 
abrupt deceleration of the A wave into a noncompliant 
left ventricle. Previously, the S4 has been associated 
with cardiac diseases that cause diastolic stiffness such 
as aortic stenosis, ischemia and left ventricular 
hypertrophy [23], and with worse prognosis following 
myocardial infarction [24]. Detected by auscultation or 
phonocardiography in healthy persons, the prevalence of 
the S4 was as high as 73% and considered, by some, to 
be a normal result of aging [25, 26]. However, more 
recent studies with acoustic cardiography have shown 
the presence of an S4 to be associated with LV stiffness 
[27]. With aging, we found an increasing percentage of 
S4 detected during sleep in agreement with Dillier et al. 
using ambulatory acoustic cardiography in asymptomatic 
adults [9] suggesting changes in LV diastolic properties 
with increasing age. 
 Prolonged electromechanical activation time is 
related to the acceleration of pressure in the left 
ventricle and thus, a marker for LV systolic dysfunction. 
Roos et al. studied a population of 108 patients 
undergoing cardiac catheterization [7] with simultaneous 
acoustic cardiography. In the group with LV systolic 
dysfunction (defined as maximum LV dP/dt < 1600 
mmHg / sec) they found EMAT to be prolonged (106 ± 
21 vs. 85 ± 11 msec), and the diagnostic performance 
of EMAT superior to QRS duration and angiographic 
ejection fraction. We report a mean EMAT of 94.2 ± 
12.4 ms during sleep which is consistent with the 
thresholds published previously for a population without 
overt cardiac disease. Further, there are no significant 
age-related increases of EMAT in our population 
consistent with the findings of Dillier et al. in an 
asymptomatic population [9] and in contrast to the 
increased night-time EMAT values seen by Dillier et al. in 
a heart failure population [10].  
 
 Efstratiadis and Michaels studied EMATc (EMAT 
divided by the cardiac cycle interval) in a population 
undergoing contemporaneous acoustic cardiography, 
cardiac catheterization and echocardiography [28]. They 
defined abnormal EMATc as ≥ 15% and found it to be 
strongly associated with impaired LV contractility but not 
associated with elevated LV filling pressure. Sung et al. 
used EMATc at a threshold of 15% to guide outpatient 
therapy of patients with acute heart failure [29] in a 
prospective single-blind randomized study. One arm was 
conventional, symptom-guided (n=92) without the 
knowledge of EMATc while the other EMATc guided 
group (n=102) had a goal to reduce EMATc to less than 
15%. Mean follow-up was 142 days and the                    
EMATc-guided management group was superior to the 
symptom-guided group with significantly better clinical 
outcomes (27 events vs 39 events). We present the first 
results of percentage of EMATc ≥ 15% during sleep 
from ambulatory acoustic cardiography in an 
asymptomatic population and report a very low median 
of 0.2% consistent with a non-acute cohort. 
 We also report the first results for percentage of 
SDI ≥ 5.0 and SDI ≥ 7.5 during sleep using ambulatory 
acoustic cardiography in a non-acute population. Using 
short acoustic cardiography recordings, SDI ≥ 5.0 has 
been shown to indicate LV systolic dysfunction and        
SDI ≥ 7.5 to indicate severe LV systolic dysfunction with 
elevated filling pressures using independent correlates of 
echocardiography ejection fraction and cardiac 
catheterization for LV end-diastolic pressure [30]. We 
observed very low percentages of SDI above threshold 
detected across all age groups suggesting high 
specificity of detection of acute cardiac disease. 
 We found a trend for higher likelihood of SDB 
for males than for females across all age groups, a 
significant increase in the likelihood of SDB for females 
with increasing age and an increasing trend of nocturnal 
non-dipping of heart rate with aging in males. Using 
acoustic cardiography in an asymptomatic population, 
Dillier et al. found a prevalence of 19% of SDB and 
9.5% rate of nocturnal non-dipping of heart rate [11] 
whereas we found 17.6% of our population had high 
likelihood of SDB and 22% of those had nocturnal              
non-dipping of heart rate. These are important findings 
as both sleep disordered breathing and heart rate, 
particularly non-dipping of heart rate during sleep, to be 
predictors of cardiovascular and non-cardiovascular risk. 
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Eguchi et al. followed 457 patients being treated or 
evaluated for hypertension [14] for an average of 72 
months and found the risk of future cardiovascular 
events (stroke, myocardial infarction or sudden cardiac 
death) or mortality was 2.4 times greater in the patients 
without the typical night-time heart rate decrease. In a 
cohort of 3,957 patients treated for hypertension,                 
Ben-Dov et al. assessed the determinants and mortality 
associations of sleep heart rate and noctural                        
non-dipping [31] and found nocturnal non-dipping was 
independently associated with all-cause mortality. The 
relationship between nocturnal non-dipping and sleep 
apnea was studied by Sasaki et al. in a group of 251 
patients with obstructive sleep apnea syndrome [32] 
over a mean follow-up period of 43 months. The non-
dipping heart rate group had significantly more 
cardiovascular events including stroke, heart failure and 
ischemic heart disease and the presence of non-dipping 
was independently associated with the incidence of CVD. 
 Limitations of this study include the small 
number of participants in this first data collection so that 
more complete subgroup analysis by age and gender is 
not possible. Additional statistical analyses after 
stratification by SDB or BMI are also not possible due to 
small subgroup sizes. Echocardiographic parameters 
were not collected during the patient assessment, thus 
not allowing acoustic cardiography parameters to be 
correlated to conventional measures of LV systolic and 
diastolic function obtained in the same patient. Acoustic 
cardiographic analysis  is limited in two ways. First, the 
acoustic cardiography analysis depends upon the quality 
of the ECG signal such that poor ECG signal due to 
artifact or other noise may reduce the analysis yield in 
the same way it does in regular ECG Holter analyses. 
Second, acoustic cardiography measurements are not 
calculated for heart rates greater than 150 bpm, which 
has not been a problem in this study population. 
Conclusion 
 Ambulatory monitoring with acoustic 
cardiography provides the means in a primary care 
setting to screen for sleep disordered breathing and 
provides markers of left ventricular systolic and diastolic 
dysfunction. The acoustic cardiography findings showed 
a low percentage of patients with abnormal systolic 
dysfunction and age-related increases in diastolic 
dysfunction in this non-acute population. The proportion 
of subjects with sleep disordered breathing increased 
with aging and was associated with known risk factors 
such as obesity. These findings represent the baseline 
characteristics of this population that will be re-
evaluated longitudinally. This initial data collection for 
SWICOS showed that ambulatory monitoring with 
acoustic cardiography is a viable and informative 
technique. 
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